Acute Response to Left Bundle Branch Area Pacing With SyncAV
Condition(s) studied
Investigational drug(s) / intervention(s)
LBBAP with SyncAV: Acute changes in surface ECG QRS duration resulting from left bundle branch area pacing using various pacing configurations will be evaluated.
Study summary
This clinical investigation is a prospective, single-arm, post-market, non-randomized, single-center study designed to evaluate the effectiveness of the SyncAV CRT dynamic atrioventricular (AV) delay feature when used with left bundle branch area pacing (LBBAP).
Eligibility
Primary outcome measure(s)
- QRS duration — During the intervention/procedure/surgery
Acute change in surface ECG QRS duration resulting from left bundle branch area pacing with optimized SyncAV, relative to intrinsic atrioventricular conduction.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| I.R.C.C.S. Policlinico San Donato | San Donato Milanese | MI | Recruiting |
More Abbott Medical Devices trials in Italy
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06436053 on ClinicalTrials.gov ↗ ← All trials in Italy